Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Memorial Healthcare System
mi
from
Hollywood, FL
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Memorial Healthcare System
mi
from
Hollywood, FL
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Metropolitan Hospital
mi
from
New York, NY
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Metropolitan Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Phoenix VA Hospital
mi
from
Phoenix, AZ
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Phoenix VA Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
University of Arizona
mi
from
Tuscon, AZ
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
University of Arizona
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Western University of Health Sciences
mi
from
Pomona, CA
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Western University of Health Sciences
mi
from
Pomona, CA
Click here to add this to my saved trials
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Status: Enrolling
Updated:  4/17/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
Status: Enrolling
Updated: 4/17/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers
Status: Enrolling
Updated:  4/23/2013
O'Connor Hospital - Wound Care Center
mi
from
San Jose, CA
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers
Status: Enrolling
Updated: 4/23/2013
O'Connor Hospital - Wound Care Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Evaluation of Proposed EZ2go Complete Bowel Cleansing System
Randomized, Single Blinded Study of Proposed EZ2go Complete Bowel Cleansing System: Evaluation of Its Safety, Efficacy and Patient Tolerance Compared to LOSO Prep, an Over the Counter Laxative Kit for Colonoscopy Bowel Preparation
Status: Enrolling
Updated:  4/23/2013
Borland-Groover Clinic
mi
from
Jacksonville, FL
Evaluation of Proposed EZ2go Complete Bowel Cleansing System
Randomized, Single Blinded Study of Proposed EZ2go Complete Bowel Cleansing System: Evaluation of Its Safety, Efficacy and Patient Tolerance Compared to LOSO Prep, an Over the Counter Laxative Kit for Colonoscopy Bowel Preparation
Status: Enrolling
Updated: 4/23/2013
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated:  4/24/2013
New York Presbyterian-Weill Cornell Medical Center
mi
from
New York, NY
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated: 4/24/2013
New York Presbyterian-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated:  4/24/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated: 4/24/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated:  4/24/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated: 4/24/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated:  4/24/2013
Yale-New Haven Hospital
mi
from
New Haven, CT
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Status: Enrolling
Updated: 4/24/2013
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Orange, CA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Roseville, CA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Littleton, CO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Bristol, CT
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Bristol, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Tampa, FL
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Fort Dodge, IA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Topeka, KA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Louisville, KY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
mi
from
Laurel, MD
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
mi
from
Laurel, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Dearborn, MI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Dearborn, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Troy, MI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Mexico, MO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
St. Louis, MO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Lebanon, NH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Great Neck, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Huntington, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Huntington, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
New York, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Charlotte, NC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Kinston, NC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Kinston, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Cincinnati, OH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Cleveland, OH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Tulsa, OK
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Philadelphia, PA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Charleston, SC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Columbia, SC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Germantown, TN
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Nashville, TN
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Austin, TX
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Galveston, TX
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Burlington, VT
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Christiansburg, VA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Christiansburg, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Richmond, VA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Bellevue, WA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Madison, WI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Milwaukee, WI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials